MedPath

KRd consolidation for newly diagnosed multiple myeloma

Not Applicable
Recruiting
Conditions
Multiple myeloma
Registration Number
JPRN-UMIN000046436
Lead Sponsor
Ochanomizu Hematology Study Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
14
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patient who has passed for more than 180 days after ASCT. 2.Patient who has progressed after ASCT

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath